Patent · US Active

Heterologous expression of neisserial proteins

US8703914B2 · kind B2 · utility

9Cited by

16References

5Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Maria Arico · Quercegrossa, IT
Maurizio Comanducci · Siena, IT
Cesira Galeotti · Poggibonsi, IT
Vega Masignani · Siena, IT
Marizia Monica Guiliani · Siena, IT
Mariagrazia Pizza · Siena, IT

Key dates

Filing date	Dec 29, 2011
Grant date	Apr 22, 2014
Priority date	—
Expiry date	Dec 29, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Alternative and improved approaches to the heterologous expression of the proteins of Neisseria meningitidis and Neisseria gonorrhoeae. These approaches typically affect the level of expression, the ease of purification, the cellular localization, and/or the immunological properties of the expressed protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.